Cash flow Albemarle Corporation

Stocks

ALB

US0126531013

Specialty Chemicals

Market Closed - NYSE 16:00:03 2026-09-14 EDT			5-day change	1st Jan Change
115.03 ^USD	-2.12%		-8.91%	-18.67%

09-03	Albemarle Corporation Announces CEO Changes, Effective February 1, 2027	CI
09-03	Albemarle Corporation Announces Board and Executive Changes	CI

f8cdc6c594eeb935c1368cc91.OIdf4J3QRJ0DcwfcbVDXQGKtwa8j3upYpDxBK9AEmkk.fshtzc7kPMxILG7oIGG8EVfHhvxHpJ9ryE8CbqAz7xt1ynKh0IQPpGoqYA

Published financial data: ALBEMARLE CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	3.33B	7.32B	9.62B	5.38B	5.14B
Total Revenues	3.33B	7.32B	9.62B	5.38B	5.14B
Cost of Goods Sold, Total	2.32B	4.24B	8.42B	5.29B	4.47B
Gross Profit	1.01B	3.08B	1.2B	84.24M	674M
Selling General & Admin Expenses, Total	347M	439M	644M	595M	543M
R&D Expenses	54.03M	71.98M	85.72M	86.72M	51.4M
Other Operating Expenses, Total	401M	511M	730M	682M	594M
Operating Income	607M	2.57B	467M	-598M	79.1M
Interest Expense, Total	-32.52M	-104M	-116M	-166M	-200M
Interest And Investment Income	-	-	19.3M	36.3M	19.8M
Net Interest Expenses	-32.52M	-104M	-96.77M	-129M	-180M
Income (Loss) On Equity Invest.	95.77M	772M	1.85B	715M	244M
Currency Exchange Gains (Loss)	100K	-21.8M	39.9M	67.5M	-18.9M
Other Non Operating Income (Expenses)	-24.74M	44.51M	80.27M	122M	80.21M
EBT, Excl. Unusual Items	646M	3.26B	2.34B	178M	204M
Restructuring Charges	-3.03M	-4.3M	-11.8M	-1.18B	-7.7M
Merger & Related Restructuring Charges	-12.67M	-16.26M	-26.77M	-6.22M	-8.3M
Impairment of Goodwill	-	-	-6.76M	-	-181M
Gain (Loss) On Sale Of Investments	-	4.3M	31.96M	-72.86M	-41.16M
Gain (Loss) On Sale Of Assets	296M	-8.4M	-	40.9M	-
Asset Writedown	-	-	-	-	-248M
Insurance Settlements	-	-	7.3M	-	-
Legal Settlements	-668M	100K	-234M	-	-2M
Other Unusual Items	-28.96M	-27.62M	-4.1M	-7.2M	-24.07M
EBT, Incl. Unusual Items	229M	3.21B	2.1B	-1.05B	-308M
Income Tax Expense	29.45M	391M	430M	87.08M	157M
Earnings From Continuing Operations	200M	2.82B	1.67B	-1.14B	-465M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	200M	2.82B	1.67B	-1.14B	-465M
Minority Interest	-76.27M	-125M	-97.07M	-43.97M	-45.42M
Net Income - (IS)	124M	2.69B	1.57B	-1.18B	-511M
Preferred Dividend and Other Adjustments	-	-	-	137M	167M
Net Income to Common Incl Extra Items	124M	2.69B	1.57B	-1.32B	-677M
Net Income to Common Excl. Extra Items	124M	2.69B	1.57B	-1.32B	-677M
Per Share Items
Net EPS - Basic	1.07	22.97	13.41	-11.2	-5.76
Basic EPS - Continuing Operations	1.07	22.97	13.41	-11.2	-5.76
Basic Weighted Average Shares Outstanding	116M	117M	117M	118M	118M
Net EPS - Diluted	1.06	22.84	13.36	-11.2	-5.76
Diluted EPS - Continuing Operations	1.06	22.84	13.36	-11.2	-5.76
Diluted Weighted Average Shares Outstanding	117M	118M	118M	118M	118M
Normalized Basic EPS	2.83	16.32	11.66	0.57	0.7
Normalized Diluted EPS	2.81	16.22	11.62	0.57	0.7
Dividend Per Share	1.56	1.58	1.6	1.61	1.62
Payout Ratio	143.81	6.86	11.9	-26.39	-69.97
American Depositary Receipts Ratio (ADR)	0.04	0.04	0.04	0.04	0.04
Supplemental Items
EBITDA	861M	2.87B	897M	-9.11M	738M
EBITA	633M	2.59B	495M	-575M	102M
EBIT	607M	2.57B	467M	-598M	79.1M
EBITDAR	923M	2.93B	991M	88.61M	847M
Effective Tax Rate - (Ratio)	12.84	12.18	20.48	-8.31	-50.88
Current Domestic Taxes	12.42M	38.2M	-57.64M	212M	-9.54M
Current Foreign Taxes	55.53M	259M	387M	105M	85.26M
Total Current Taxes	67.95M	297M	329M	317M	75.71M
Deferred Domestic Taxes	-43.96M	80.54M	-12.7M	-171M	74.24M
Deferred Foreign Taxes	5.46M	12.8M	114M	-59.46M	6.93M
Total Deferred Taxes	-38.5M	93.34M	101M	-230M	81.17M
Normalized Net Income	327M	1.91B	1.37B	67.09M	81.94M
Interest Capitalized	50M	31.1M	72.7M	49M	18.5M
Interest on Long-Term Debt	82.48M	135M	189M	215M	226M
Non-Cash Pension Expense	-77.37M	-48.09M	-2.95M	-18.96M	2.69M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	54.03M	71.98M	85.72M	86.72M	51.4M
Net Rental Expense, Total	61.42M	65.86M	93.62M	97.72M	110M
Imputed Operating Lease Interest Expense	12.95M	24.07M	36.9M	42.16M	55.02M
Imputed Operating Lease Depreciation	48.48M	41.79M	56.72M	55.56M	54.58M
Stock-Based Comp., Other (Total)	18.8M	31.4M	39M	33.1M	36.6M
Total Stock-Based Compensation	18.8M	31.4M	39M	33.1M	36.6M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	439M	1.5B	890M	1.19B	1.62B
Total Cash And Short Term Investments	439M	1.5B	890M	1.19B	1.62B
Accounts Receivable, Total	557M	1.19B	1.21B	742M	594M
Other Receivables	143M	258M	622M	323M	171M
Total Receivables	700M	1.45B	1.84B	1.07B	765M
Inventory	813M	2.08B	2.16B	1.5B	1.18B
Prepaid Expenses	49.93M	156M	324M	77.19M	71.9M
Other Current Assets, Total	5.8M	6.72M	6.6M	4.75M	374M
Total Current Assets	2.01B	5.19B	5.22B	3.84B	4.01B
Gross Property Plant And Equipment	8.23B	9.48B	12.37B	12.64B	11.89B
Accumulated Depreciation	-2.17B	-2.39B	-2.74B	-3.19B	-3.16B
Net Property Plant And Equipment	6.06B	7.09B	9.63B	9.45B	8.73B
Long-term Investments	898M	1.15B	1.37B	1.12B	901M
Goodwill	1.6B	1.62B	1.63B	1.58B	1.5B
Other Intangibles, Total	309M	288M	262M	231M	214M
Deferred Tax Assets Long-Term	18.8M	46.43M	22.43M	53.61M	17.54M
Other Long-Term Assets, Total	78.7M	75.95M	137M	332M	1B
Total Assets	10.97B	15.46B	18.27B	16.61B	16.37B
Liabilities
Accounts Payable, Total	648M	2.05B	2.09B	944M	914M
Accrued Expenses, Total	266M	396M	514M	435M	140M
Current Portion of Long-Term Debt	388M	-	620M	393M	70M
Current Portion of Leases	33.02M	37.64M	36.34M	37.81M	28.64M
Current Income Taxes Payable	27.67M	135M	255M	95.28M	35.47M
Unearned Revenue Current, Total	-	-	-	-	93.09M
Other Current Liabilities	511M	121M	46.67M	61.28M	517M
Total Current Liabilities	1.87B	2.74B	3.56B	1.97B	1.8B
Long-Term Debt	1.93B	3.14B	3.44B	3B	3.02B
Long-Term Leases	201M	174M	218M	213M	206M
Unearned Revenue Non Current	-	-	78.03M	78.03M	341M
Pension & Other Post Retirement Benefits	273M	192M	177M	148M	162M
Deferred Tax Liability Non Current	353M	481M	558M	358M	368M
Other Non Current Liabilities	537M	537M	577M	642M	701M
Total Liabilities	5.17B	7.27B	8.61B	6.41B	6.59B
Preferred Stock Convertible	-	-	-	2.24B	2.24B
Total Preferred Equity	-	-	-	2.24B	2.24B
Common Stock, Total	1.17M	1.17M	1.17M	1.18M	1.18M
Additional Paid In Capital	2.92B	2.94B	2.95B	2.99B	3.02B
Retained Earnings	3.1B	5.6B	6.99B	5.48B	4.61B
Comprehensive Income and Other	-392M	-561M	-529M	-742M	-335M
Total Common Equity	5.63B	7.98B	9.41B	7.73B	7.3B
Minority Interest	180M	208M	253M	238M	248M
Total Equity	5.81B	8.19B	9.67B	10.2B	9.78B
Total Liabilities And Equity	10.97B	15.46B	18.27B	16.61B	16.37B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	117M	117M	117M	118M	118M
ECS Total Common Shares Outstanding	117M	117M	117M	118M	118M
Book Value / Share	48.07	68.13	80.2	65.72	62
Tangible Book Value	3.72B	6.08B	7.52B	5.91B	5.58B
Tangible Book Value Per Share	31.78	51.87	64.08	50.3	47.44
Total Debt	2.55B	3.35B	4.31B	3.65B	3.32B
Net Debt	2.08B	1.81B	3.21B	2.4B	1.64B
Debt Equivalent of Unfunded Proj. Benefit Obligation	236M	167M	159M	123M	125M
Debt Equivalent Oper. Leases	491M	527M	749M	782M	877M
Minority Interest, Total (Incl. Fin. Div)	180M	208M	253M	238M	248M
Equity Method Investments, Total	593M	832M	855M	727M	820M
Account Code - Inventory Valuation	5	5	5	5	5
LIFO Reserve, Total	45.3M	57.9M	60.1M	67.1M	67.8M
Inventories - Raw Materials, Total	110M	164M	188M	138M	116M
Inventories - Work In Process, Total	149M	133M	213M	291M	298M
Inventories - Finished Goods, Total	474M	1.68B	1.62B	913M	621M
Inventories - Others	79.86M	99.56M	135M	161M	144M
Land - (BS)	118M	172M	297M	295M	266M
Buildings, Total	384M	493M	699M	933M	937M
Machinery, Total	3.62B	4.45B	6.17B	8.19B	7.81B
Full Time Employees	6K	7.4K	9K	8.3K	7.8K
Accumulated Allowance for Doubtful Accounts (Supple)	2.56M	2.53M	2.81M	5.2M	4.58M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	124M	2.69B	1.57B	-1.18B	-511M
Depreciation & Amortization - CF	229M	276M	402M	566M	636M
Amortization of Goodwill and Intangible Assets - (CF)	25.33M	24.71M	28.03M	23.04M	22.43M
Depreciation & Amortization, Total	254M	301M	430M	589M	659M
(Gain) Loss From Sale Of Asset	-296M	8.4M	-71.19M	-	-
(Gain) Loss on Sale of Investments - (CF)	-3.82M	3.28M	39.86M	63.82M	-14.09M
Asset Writedown & Restructuring Costs	-	-	-	1.01B	427M
(Income) Loss On Equity Investments - (CF)	-95.77M	-772M	-1.85B	-715M	-244M
Stock-Based Compensation (CF)	20.12M	30.47M	36.54M	32.14M	40.27M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	230M	1.06B	2.69B	-459M	231M
Change In Accounts Receivable	-49.3M	-786M	-351M	555M	47.32M
Change In Inventories	-127M	-1.61B	-963M	1.56B	212M
Change In Accounts Payable	144M	1.29B	-283M	-862M	128M
Change in Other Net Operating Assets	144M	-306M	81.65M	105M	307M
Cash from Operations	344M	1.91B	1.33B	702M	1.28B
Capital Expenditure	-954M	-1.26B	-2.15B	-1.69B	-590M
Sale of Property, Plant, and Equipment	-	-	-	29.1M	32.81M
Cash Acquisitions	-	-162M	-426M	-	-
Divestitures	290M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-2.71M	1.24M	-206M	82.25M	297M
Other Investing Activities, Total	-	-	-	-	114M
Cash from Investing	-667M	-1.42B	-2.78B	-1.57B	-146M
Long-Term Debt Issued, Total	60.99M	1.96B	973M	112M	56.73M
Total Debt Issued	60.99M	1.96B	973M	112M	56.73M
Long-Term Debt Repaid, Total	-1.17B	-1.1B	-28.86M	-744M	-511M
Total Debt Repaid	-1.17B	-1.1B	-28.86M	-744M	-511M
Issuance of Common Stock	1.47B	2.78M	190K	374K	3.24M
Repurchase of Common Stock	-8.14M	-13.34M	-27.47M	-11.89M	-7.26M
Issuance of Preferred Stock	-	-	-	2.24B	-
Common Dividends Paid	-178M	-184M	-187M	-189M	-191M
Preferred Dividends Paid	-	-	-	-123M	-167M
Common & Preferred Stock Dividends Paid	-178M	-184M	-187M	-311M	-357M
Other Financing Activities, Total	-123M	-60.68M	-106M	-40.39M	-18.22M
Cash from Financing	50.21M	612M	624M	1.24B	-834M
Foreign Exchange Rate Adjustments	-35.33M	-37.22M	223M	-67.04M	124M
Net Change in Cash	-307M	1.06B	-609M	302M	426M
Supplemental Items
Cash Interest Paid	27.73M	92.1M	102M	151M	181M
Cash Income Tax Paid (Refund)	131M	248M	319M	263M	152M
Levered Free Cash Flow	47.09M	-273M	-1.9B	-1.23B	453M
Unlevered Free Cash Flow	67.42M	-208M	-1.83B	-1.13B	578M
Change In Net Working Capital	-369M	883M	438M	-309M	-423M
Net Debt Issued / Repaid	-1.11B	868M	944M	-632M	-455M

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	3.54	12.14	1.73	-2.14	0.3
Return on Total Capital	4.59	16.12	2.29	-2.69	0.37
Return On Equity %	3.89	40.23	18.71	-11.43	-4.66
Return on Common Equity	2.5	39.53	18.09	-15.36	-9.02
Margin Analysis
Gross Profit Margin %	30.3	42.05	12.45	1.57	13.1
SG&A Margin	10.43	6	6.7	11.07	10.56
EBITDA Margin %	25.88	39.17	9.33	-0.17	14.35
EBITA Margin %	19.01	35.4	5.15	-10.69	1.97
EBIT Margin %	18.25	35.06	4.86	-11.12	1.54
Income From Continuing Operations Margin %	6.01	38.46	17.37	-21.12	-9.05
Net Income Margin %	3.72	36.75	16.36	-21.93	-9.93
Net Avail. For Common Margin %	3.72	36.75	16.36	-24.47	-13.17
Normalized Net Income Margin	9.84	26.1	14.23	1.25	1.59
Levered Free Cash Flow Margin	1.42	-3.73	-19.75	-22.92	8.81
Unlevered Free Cash Flow Margin	2.03	-2.84	-19	-20.99	11.25
Asset Turnover
Asset Turnover	0.31	0.55	0.57	0.31	0.31
Fixed Assets Turnover	0.58	1.11	1.15	0.56	0.57
Receivables Turnover (Average Receivables)	6.12	8.38	8	5.5	7.7
Inventory Turnover (Average Inventory)	2.97	2.95	3.97	2.89	3.33
Short Term Liquidity
Current Ratio	1.07	1.89	1.47	1.95	2.23
Quick Ratio	0.61	1.08	0.77	1.15	1.33
Operating Cash Flow to Current Liabilities	0.18	0.7	0.37	0.36	0.71
Days Sales Outstanding (Average Receivables)	59.65	43.58	45.62	66.54	47.4
Days Outstanding Inventory (Average Inventory)	122.99	123.66	91.84	126.67	109.51
Average Days Payable Outstanding	86.66	89.27	88.83	119.72	81.76
Cash Conversion Cycle (Average Days)	95.98	77.97	48.63	73.49	75.15
Long Term Solvency
Total Debt/Equity	43.97	40.92	44.6	35.77	33.95
Total Debt / Total Capital	30.54	29.04	30.85	26.35	25.35
LT Debt/Equity	36.71	40.46	37.81	31.55	32.95
Long-Term Debt / Total Capital	25.5	28.71	26.15	23.24	24.59
Total Liabilities / Total Assets	47.1	47.01	47.1	38.59	40.26
EBIT / Interest Expense	18.68	24.74	4.02	-3.61	0.4
EBITDA / Interest Expense	28.37	28.27	8.54	0.54	4.23
(EBITDA - Capex) / Interest Expense	-0.95	16.11	-9.98	-9.64	1.29
Total Debt / EBITDA	2.77	1.14	4.35	41.17	3.92
Net Debt / EBITDA	2.25	0.62	3.24	27.03	1.93
Total Debt / (EBITDA - Capex)	-82.66	2.01	-3.72	-2.28	12.89
Net Debt / (EBITDA - Capex)	-67.23	1.08	-2.77	-1.5	6.36
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	6.36	119.96	31.38	-44.08	-4.37
Gross Profit, 1 Yr. Growth %	1.17	205.19	-61.11	-92.96	699.53
EBITDA, 1 Yr. Growth %	16.01	231.44	-68.72	-101.02	-8.2K
EBITA, 1 Yr. Growth %	18.17	307.13	-80.89	-216.07	-117.67
EBIT, 1 Yr. Growth %	18.98	319.97	-81.8	-227.97	-113.23
Earnings From Cont. Operations, 1 Yr. Growth %	-55.23	1.31K	-40.66	-167.97	-59.03
Net Income, 1 Yr. Growth %	-67.09	2.07K	-41.5	-174.96	-56.71
Normalized Net Income, 1 Yr. Growth %	22.03	479.33	-28.39	-95.1	22.13
Diluted EPS Before Extra, 1 Yr. Growth %	-69.89	2.05K	-41.51	-183.83	-48.57
Accounts Receivable, 1 Yr. Growth %	4.91	113.85	1.86	-38.82	-20.03
Inventory, 1 Yr. Growth %	8.36	159.95	4.11	-30.48	-21.51
Net Property, Plant and Equip., 1 Yr. Growth %	10.44	16.93	35.84	-1.89	-7.63
Total Assets, 1 Yr. Growth %	5.01	40.85	18.21	-9.09	-1.42
Tangible Book Value, 1 Yr. Growth %	65.01	63.42	23.75	-21.38	-5.56
Common Equity, 1 Yr. Growth %	31.79	41.91	17.91	-17.91	-5.54
Cash From Operations, 1 Yr. Growth %	-56.91	454.19	-30.53	-47.03	86.41
Capital Expenditures, 1 Yr. Growth %	12.13	32.29	70.36	-21.56	-64.9
Levered Free Cash Flow, 1 Yr. Growth %	-111.86	-527.93	596.03	-35.11	-136.94
Unlevered Free Cash Flow, 1 Yr. Growth %	-119.19	-347.39	778.11	-38.2	-151.47
Dividend Per Share, 1 Yr. Growth %	1.3	1.28	1.27	0.62	0.62
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.71	52.95	69.99	-14.29	-26.87
Gross Profit, 2 Yr. CAGR %	-10.48	75.71	8.94	-83.46	-24.51
EBITDA, 2 Yr. CAGR %	-4.44	96.52	1.25	-94.36	5.99
EBITA, 2 Yr. CAGR %	-8.57	120.01	-12.48	-52.91	-36.87
EBIT, 2 Yr. CAGR %	-8.77	124.23	-13.28	-51.74	-40.94
Earnings From Cont. Operations, 2 Yr. CAGR %	-42.48	151.06	189.05	-36.49	-47.23
Net Income, 2 Yr. CAGR %	-51.84	167.55	256.69	-33.78	-43.03
Normalized Net Income, 2 Yr. CAGR %	-12.27	166.85	94.77	-81.26	-74.06
Diluted EPS Before Extra, 2 Yr. CAGR %	-54.05	154.73	255.02	-29.97	-34.34
Accounts Receivable, 2 Yr. CAGR %	-4.66	49.79	47.59	-21.06	-30.06
Inventory, 2 Yr. CAGR %	2.82	66.35	64.51	-14.93	-26.13
Net Property, Plant and Equip., 2 Yr. CAGR %	9.66	13.64	26.03	15.44	-4.81
Total Assets, 2 Yr. CAGR %	5.49	21.61	29.03	3.66	-5.33
Tangible Book Value, 2 Yr. CAGR %	36.4	64.21	42.21	-1.36	-13.83
Common Equity, 2 Yr. CAGR %	19.61	36.76	29.35	-1.62	-11.94
Cash From Operations, 2 Yr. CAGR %	-30.82	54.53	96.21	-39.34	-1.68
Capital Expenditures, 2 Yr. CAGR %	5.81	21.8	50.12	15.59	-47.68
Levered Free Cash Flow, 2 Yr. CAGR %	8.23	-17.09	420.9	112.52	-53.03
Unlevered Free Cash Flow, 2 Yr. CAGR %	206.81	-23.04	349.72	132.95	-45.98
Dividend Per Share, 2 Yr. CAGR %	3.02	1.29	1.27	0.94	0.62
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-0.47	26.81	45.4	17.35	-11.1
Gross Profit, 3 Yr. CAGR %	-6.53	34.73	6.29	-56.29	-39.74
EBITDA, 3 Yr. CAGR %	-3.23	44.86	6.51	-78.16	-36.4
EBITA, 3 Yr. CAGR %	-6.65	50.72	-2.57	-3.84	-66.04
EBIT, 3 Yr. CAGR %	-6.78	52.08	-2.91	-1.27	-68.65
Earnings From Cont. Operations, 3 Yr. CAGR %	-35.33	67.01	55.23	78.41	-45.12
Net Income, 3 Yr. CAGR %	-43.71	71.5	61.18	112.07	-42.53
Normalized Net Income, 3 Yr. CAGR %	-9.43	64.99	72.12	-42.92	-65
Diluted EPS Before Extra, 3 Yr. CAGR %	-44.91	65.7	55.99	119.43	-36.82
Accounts Receivable, 3 Yr. CAGR %	-2.76	24.8	31.72	10.05	-20.72
Inventory, 3 Yr. CAGR %	5.08	39.24	42.29	23.45	-17.18
Net Property, Plant and Equip., 3 Yr. CAGR %	26.15	12.03	20.61	15.94	7.17
Total Assets, 3 Yr. CAGR %	13.12	16.16	20.47	14.81	1.94
Tangible Book Value, 3 Yr. CAGR %	31.59	44.87	49.44	16.72	-2.78
Common Equity, 3 Yr. CAGR %	16.2	26.62	30.16	11.16	-2.94
Cash From Operations, 3 Yr. CAGR %	-14.26	38.42	18.38	26.81	-12.41
Capital Expenditures, 3 Yr. CAGR %	10.86	13.99	36.21	20.91	-22.39
Levered Free Cash Flow, 3 Yr. CAGR %	-4.56	89.34	68.51	160.15	18.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	46.56	207.4	73.26	132.07	40.61
Dividend Per Share, 3 Yr. CAGR %	5.2	2.43	1.28	1.06	0.84
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.45	18.97	23.3	8.42	10.45
Gross Profit, 5 Yr. CAGR %	0.77	21.86	-0.62	-41.77	-7.54
EBITDA, 5 Yr. CAGR %	3.43	27.73	-1.15	-60.46	-0.13
EBITA, 5 Yr. CAGR %	2.63	31	-8.63	-5.36	-28.29
EBIT, 5 Yr. CAGR %	2.51	31.75	-9.03	-3.91	-31.13
Earnings From Cont. Operations, 5 Yr. CAGR %	-16.02	95.15	17.71	13.44	0.82
Net Income, 5 Yr. CAGR %	-28.1	117.83	17.8	17.21	6.33
Normalized Net Income, 5 Yr. CAGR %	1.85	38.54	25.43	-30.89	-21.12
Diluted EPS Before Extra, 5 Yr. CAGR %	-22.94	115.63	16.08	17.41	10.35
Accounts Receivable, 5 Yr. CAGR %	2.76	17.39	14.9	3.91	2.26
Inventory, 5 Yr. CAGR %	12.54	28.49	25.27	14.34	9.47
Net Property, Plant and Equip., 5 Yr. CAGR %	20.77	23.25	26.1	13.38	9.71
Total Assets, 5 Yr. CAGR %	6.1	14.8	19.23	10.99	9.4
Tangible Book Value, 5 Yr. CAGR %	14.37	29.91	35.74	24.22	19.9
Common Equity, 5 Yr. CAGR %	8.19	16.79	21.29	14.46	11.33
Cash From Operations, 5 Yr. CAGR %	-14.09	44.39	19.4	-0.49	9.92
Capital Expenditures, 5 Yr. CAGR %	37.13	31.76	25.15	14.63	-7.06
Levered Free Cash Flow, 5 Yr. CAGR %	-43.78	12.21	103.69	98.29	2.69
Unlevered Free Cash Flow, 5 Yr. CAGR %	-40.15	12.73	143.33	175.12	10.49
Dividend Per Share, 5 Yr. CAGR %	5.04	4.3	3.61	1.84	1.02